Mark Lampert, Biotechnology Value Fund Up Stake In Cytokinetics, Inc. (CYTK), Reduce Exposure To Regado Biosciences Inc (RGDO)

Mark Lampert, the founder and manager of Biotechnology Value Fund, is bullish on Cytokinetics, Inc. (NASDAQ:CYTK). According to a recent filing with the Securities and Exchange Commission, Lampert has increased his fund’s stake from 1.79 million to 3.28 million shares, which include some 921,100 shares which can be issued upon the exercise of certain warrants. The fund’s current position accounts for 9.98% of the company’s common stock.

In another filing with the SEC, Biotechnology Value Fund has revealed a reduction in its holding of Regado Biosciences Inc (NASDAQ:RGDO) by 1.32 million shares that were disposed of, leaving the fund with 2.33 million shares which account for 9.99% of the company’s common stock.

Cytokinetics, Inc. (NASDAQ:CYTK)

Cytokinetics, Inc. (NASDAQ:CYTK) has also attracted the attention of Paul Ruddock and Steve Heinz, the managers of Lansdowne Partners. According to the fund’s latest 13F report, it holds 2.02 million shares valued at $13.1 million, the position suffering no changes in the previous quarter. Jim Simmons is also bullish on this stock, having initiated a position during the fourth quarter of 2013. Renaissance Technologies reported the ownership of 335,300 shares worth $2.17 million in its latest 13F filing. Israel Englander, the manager of Millennium Management, has decided to limit his exposure to Cytokinetics and has decreased his fund’s position by 36% to 554,700 shares valued at $3.6 million.

Cytokinetics, Inc. (NASDAQ:CYTK) engages in the research and design of small molecule therapeutics. The stock has a market cap of $326 million and does not pay a dividend. The stock has entered an uptrend at the end of 2013 and has advanced 38% so far this year to a current price of $8.95 per share. For the three months ending December 31, 2014, Cytokinetics posted revenues of $24.35 million and earnings per share of $0.22, up from a loss of $0.48 per share reported for the same period in 2012. Analysts expect the company to register $7.69 million in revenues and a loss per share of $0.35 during the current quarter.

Regado Biosciences Inc (NASDAQ:RGDO)

Only two hedge funds that we track have invested in Regado Biosciences Inc (NASDAQ:RGDO), one of them being Wexford Capital run by Charles Davidson. According to the fund’s latest 13F report, during the previous quarter, it has decreased its holding of the stock by 9% to 324,200 shares valued at $1.54 million. Alyeska Investment Group and its manager, Anand Parekh, are actually bullish and have increased their holding by 76% to 116,000 shares reportedly worth $553,000.

A developer of antithrombotic drug systems, Regado Biosciences Inc (NASDAQ:RGDO) has a market cap of $303 million and does not pay a dividend. The stock has been in an uptrend since the start of the year and has advanced 145% to a current price of $12 per share. For the year ending December 31, 2013, the company posted a net loss of $34.4 million, which translated into a loss per share of $4.59.

Disclosure: none.

Recommended reading:

CST Brands Inc (CST): Another Spin-Off Favored by Hedge Funds

Hedge Funds Go Crazy for Carter’s, Inc. (CRI)

Park West Asset Management Boosts Passive Stake In Move Inc. (MOVE)

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

6 Movies That You Should Watch to Better Understand The Cold War

Top 15 Best Paying Jobs for Women in 2014

Top 6 Things Rich People Do Differently Every Day

5 Retirement Mistakes To Avoid (and Einstein’s Famous Quote)

11 Smartest People in the World

6 Films About the Financial World You Need To Watch (While “The Wolf” is Not Around)

Warren Buffett and Billionaires Are Crazy About These 7 Stocks

The Top 10 States With Fastest Internet Speeds

10 Best Places to Visit in USA in August

Top 10 Cities to Visit Before You Die

Top 10 Genetically Modified Food In the US

15 Highest Grossing Movies Opening Weekend

5 Best Poker Books For Beginners

10 Strategies Hedge Funds Use to Make Huge Returns

Top 10 Fast Food Franchises to Buy

10 Best Places to Visit in Canada

Best Summer Jobs for Teachers

10 Youngest Hedge Fund Billionaires

Top 10 One Hit Wonders of the 90s

Fastest Growing Cities In America

Top 10 U.S. Cities for Freelancers

Top 9 Most Popular Free iPhone Apps

Top 10 Least Expensive Private Business Schools in the US

Top 15 Most Expensive Countries in the World – 2014

Top 6 Tax Scams and How to Protect Yourself

Top Businesses to Invest In

Top 5 Things You Might Be Doing Wrong With Your Business

Top 5 Strategic Technology Trends in 2014

Top Rags to Riches Stories

Parenting Behavior That Promotes Future Leaders

Top 5 Mistakes Made by Small Businesses

Top 5 Most Common and Potentially Devastating Financial Blunders

Top 5 Highest Paying Jobs for Web Designers

Top 6 Most Respected Professions that Also Pay Well

Top 5 Pitfalls Investors Should Avoid

Top 6 Lawyers and Policy Makers Under 30

Top 6 New Year’s Resolutions for Entrepreneurs

Top 7 Locations to Check in on Facebook

Top 5 Mistakes made by Rookie eBay Sellers

Top 7 eBook Publishers in 2013

Top 6 Health Industry Trends in 2014

5 Lessons for Entrepreneurs from Seth Godin

Top 5 Success Tips from Jordan Belfort – the Wolf of Wall Street

Best Master’s in Finance Degree Programs

Top 6 Earning Celebrities Over 50

The most expensive sports to play

Top 7 Earning Celebrities Under 25

Best 7 Online Courses to Take: Free Finance MOOCs

Top 6 Bad Habits that Promote Failure

20 Most Valuable Soccer Teams in the World in 2013

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!